Uremic- and Dialysis-Associated Pericarditis.


Journal

Cardiology in review
ISSN: 1538-4683
Titre abrégé: Cardiol Rev
Pays: United States
ID NLM: 9304686

Informations de publication

Date de publication:
Historique:
pubmed: 19 12 2020
medline: 29 12 2021
entrez: 18 12 2020
Statut: ppublish

Résumé

Uremic pericarditis occurs as a result of inflammation of the pericardium due to toxins and immune complexes in patients with renal disease. The initial clinical manifestations of pericarditis and acute coronary syndrome may be similar, and initial EKG findings may overlap. The management of this disease needs the combined efforts of internists, cardiologists, and nephrologists. Its incidence has been reduced since the introduction of renal replacement therapy. Dialysis continues to be the mainstay of treatment.

Identifiants

pubmed: 33337656
doi: 10.1097/CRD.0000000000000381
pii: 00045415-202111000-00008
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

310-313

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure: The authors have no conflicts of interest to report.

Références

Rostand SG, Rutsky EA. Pericarditis in end-stage renal disease. Cardiol Clin. 1990;8:701–707.
Rutsky EA, Rostand SG. Treatment of uremic pericarditis and pericardial effusion. Am J Kidney Dis. 1987;10:2–8.
Lundin AP. Recurrent uremic pericarditis: a mark of inadequate dialysis. Sem Dialysis. 2007;3:5–7.
Keith NM, Keys TE. Contributions of Richard Bright and his associates to renal disease. AMA Arch Intern Med. 1954;94:5–21.
Langendorf R, Pirani CL. The heart in uremia; an electrocardiographic and pathologic study. Am Heart J. 1947;33:282–307.
Wacker W, Merrill JP. Uremic pericarditis in acute and chronic renal failure. J Am Med Assoc. 1954;156:764–765.
Rehman KA, Betancor J, Xu B, et al. Uremic pericarditis, pericardial effusion, and constrictive pericarditis in end-stage renal disease: insights and pathophysiology. Clin Cardiol. 2017;40:839–846.
Kleiman JH, Motta J, London E, et al. Pericardial effusions in patients with end-stage renal disease. Br Heart J. 1978;40:190–193.
Alpert MA, Ravenscraft MD. Pericardial involvement in end-stage renal disease. Am J Med Sci. 2003;325:228–236.
Bailey GL, Hampers CL, Hager EB, et al. Uremic pericarditis. Clinical features and management. Circulation. 1968;38:582–591.
Fuller TJ, Knochel JP, Brennan JP, et al. Reversal of intractable uremic pericarditis by triamcinolone hexacetonide. Arch Intern Med. 1976;136:979–982.
Ribot S, Frankel HJ, Gielchinsky I, et al. Treatment of uremic pericarditis. Clin Nephrol. 1974;2:127–130.
Silverberg S, Oreopoulos DG, Wise DJ, et al. Pericarditis in patients undergoing long-term hemodialysis and peritoneal dialysis. Incidence, complications and management. Am J Med. 1977;63:874–879.
Beaudry C, Nakamoto S, Kolff WJ. Uremic pericarditis and cardiac tamponade in chronic renal failure. Ann Intern Med. 1966;64:990–995.
Marini PV, Hull AR. Uremic pericarditis: a review of incidence and management. Kidney Int Suppl. 1975:163–166.
Wolfe SA, Bailey GF, Collins JJ Jr. Constrictive pericarditis following uremic effusion. J Thorac Cardiovasc Surg. 1972;63:540–544.
Johnson RJ, Nakagawa T, Jalal D, et al. Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transplant. 2013;28:2221–2228.
Twardowski ZJ, Alpert MA, Gupta RC, et al. Circulating immune complexes: possible toxins responsible for serositis (pericarditis, pleuritis, and peritonitis) in renal failure. Nephron. 1983;35:190–195.
Maisch B, Kochsiek K. Humoral immune reactions in uremic pericarditis. Am J Nephrol. 1983;3:264–271.
Alfrey AC, Goss JE, Ogden DA, et al. Uremic hemopericardium. Am J Med. 1968;45:391–400.
Comty CM, Cohen SL, Shapiro FL. Pericarditis in chronic uremia and its sequels. Ann Intern Med. 1971;75:173–183.
Spodick DH. Frequency of arrhythmias in acute pericarditis determined by Holter monitoring. Am J Cardiol. 1984;53:842–845.
Dad T, Sarnak MJ. Pericarditis and pericardial effusions in end-stage renal disease. Semin Dial. 2016;29:366–373.
Snyder MJ, Bepko J, White M. Acute pericarditis: diagnosis and management. Am Fam Physician. 2014;89:553–560.
Maisch B, Seferović PM, Ristić AD, et al.; Task Force on the Diagnosis and Management of Pricardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. 2004;25:587–610.
Bostick B, Whaley-Connell A. The use and interpretation of troponin in ESRD patients. Semin Dial. 2014;27:545–547.
Gunukula SR, Spodick DH. Pericardial disease in renal patients. Semin Nephrol. 2001;21:52–56.
Horton JD, Gelfand MC, Sherber HS. Natural history of asymptomatic pericardial effusions in patients on maintenance hemodialysis. Proc Clin Dial Transplant Forum. 1977;7:76–81.
Yoshida K, Shiina A, Asano Y, et al. Uremic pericardial effusion: detection and evaluation of uremic pericardial effusion by echocardiography. Clin Nephrol. 1980;13:260–268.
Ravi V, Iskander F, Saini A, et al. Clinical predictors and outcomes of patients with pericardial effusion in chronic kidney disease. Clin Cardiol. 2018;41:660–665.
El-Said W, Gabal IA. Treatment of uremic pericarditis and pericardial effusion by augmented hemodialysis. Int Urol Nephrol. 1978;10:53–58.
Morin JE, Hollomby D, Gonda A, et al. Management of uremic pericarditis: a report of 11 patients with cardiac tamponade and a review of the literature. Ann Thorac Surg. 1976;22:588–592.
Ventura SC, Garella S. The management of pericardial disease in renal failure. Semin Dialysis. 2007;3:21–26.
Cohen GF, Burgess JH, Kaye M. Peritoneal dialysis for the treatment of pericarditis in patients on chronic hemodialysis. Can Med Assoc J. 1970;102:1365–1368.
Ifudu O. Daily dialysis in hemodialysis patients with pericardial effusion: where are the data? Int J Artif Organs. 1999;22:469–470.
Spector D, Alfred H, Siedlecki M, et al. A controlled study of the effect of indomethacin in uremic pericarditis. Kidney Int. 1983;24:663–669.
Tomkowski W, Swedberg K, Seferovic P, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases. Eur Heart Jl. 2015;36:2921–2964.
Minuth AN, Nottebohm GA, Eknoyan G, et al. Indomethacin treatment of pericarditis in chronic hemodialysis patients. Arch Intern Med. 1975;135:807–810.
Eliasson G, Murphy JF. Steroid therapy in uremic pericarditis. A report of three cases. JAMA. 1974;229:1634–1635.
Maisch B, Ristić AD, Pankuweit S. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone. The way to avoid side effects of systemic corticosteroid therapy. Euro Heart J. 2002;23:1503–1508.
Buselmeier TJ, Davin TD, Simmons RL, et al. Treatment of intractable uremic pericardial effusion. Avoidance of pericardiectomy with local steroid instillation. JAMA. 1978;240:1358–1359.
Wood JE, Mahnensmith RL. Pericarditis associated with renal failure: evolution and management. Semin Dial. 2001;14:61–66.
Figueroa W, Alankar S, Pai N, et al. Subxiphoid pericardial window for pericardial effusion in end-stage renal disease. Am J Kidney Dis. 1996;27:664–667.
Daugirdas JT, Leehey DJ, Popli S, et al. Subxiphoid pericardiostomy for hemodialysis-associated pericardial effusion. Arch Intern Med. 1986;146:1113–1115.
Schlein EM, Bartley TD, Spooner GR, et al. A simplified surgical approach to therapy of uremic pericarditis with tamponade. Ann Thorac Surg. 1970;10:548–551.
Colak A, Becit N, Kaya U, et al. Treatment of pericardial effusion through subxiphoid tube pericardiostomy and computerized tomography- or echocardiography - guided percutaneous catheter drainage methods. Braz J Cardiovasc Surg. 2019;34:194–202.
Mashahdian A. Uremic pericarditis: a report of 30 cases and review of the literature. Am J Case Rep. 2014;15:169–173.

Auteurs

Savneek Chugh (S)

From the Department of Medicine, Division of Nephrology, New York Medical College/Westchester Medical Center, Valhalla, NY.

Jagmeet Singh (J)

Department of Medicine, Geisinger Commonwealth School of Medicine, Scranton, PA.

Asim Kichloo (A)

Department of Medicine, Central Michigan University, Saginaw, MI.

Sanjeev Gupta (S)

From the Department of Medicine, Division of Nephrology, New York Medical College/Westchester Medical Center, Valhalla, NY.

Tasleem Katchi (T)

Division of Cardiology, Aventura Hospital and Medical Center, Aventura, FL.

Shantanu Solanki (S)

Department of Medicine, Geisinger Commonwealth School of Medicine, Scranton, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH